Benjamin G Hale

InstitutionUniversity of Zurich
AddressZurich
Switzerland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in March 2021 and June 2021
    All Publications
    Bar chart showing 32 publications over 14 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pohl MO, Busnadiego I, Marrafino F, Wiedmer L, Hunziker A, Fernbach S, Glas I, Moroz-Omori EV, Hale BG, Caflisch A, Stertz S. Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir. J Gen Virol. 2021 07; 102(7). PMID: 34319869.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    2. Echavarría-Consuegra L, Cook GM, Busnadiego I, Lefèvre C, Keep S, Brown K, Doyle N, Dowgier G, Franaszek K, Moore NA, Siddell SG, Bickerton E, Hale BG, Firth AE, Brierley I, Irigoyen N. Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection. PLoS Pathog. 2021 06; 17(6):e1009644. PMID: 34138976.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    3. Palika A, Armanious A, Rahimi A, Medaglia C, Gasbarri M, Handschin S, Rossi A, Pohl MO, Busnadiego I, Gübeli C, Anjanappa RB, Bolisetty S, Peydayesh M, Stertz S, Hale BG, Tapparel C, Stellacci F, Mezzenga R. An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles. Nat Nanotechnol. 2021 08; 16(8):918-925. PMID: 34083772.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    4. Hale BG. Avoiding culture shock with the SARS-CoV-2 spike protein. Elife. 2021 05 18; 10. PMID: 34003114.
      Citations:    Fields:    Translation:HumansAnimals
    5. Pohl MO, Busnadiego I, Kufner V, Glas I, Karakus U, Schmutz S, Zaheri M, Abela I, Trkola A, Huber M, Stertz S, Hale BG. SARS-CoV-2 variants reveal features critical for replication in primary human cells. PLoS Biol. 2021 03; 19(3):e3001006. PMID: 33760807.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    6. Stertz S, Hale BG. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. 2021 11; 29(11):973-982. PMID: 33757684.
      Citations: 9     Fields:    Translation:HumansAnimals
    7. Busnadiego I, Fernbach S, Pohl MO, Karakus U, Huber M, Trkola A, Stertz S, Hale BG. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. mBio. 2020 09 10; 11(5). PMID: 32913009.
      Citations: 38     Fields:    Translation:HumansAnimalsCellsPHPublic Health